Search Results - "Graus, F."

40 years of autoantibody research in paraneoplastic neurological syndromes by Graus, F.

“…Paraneoplastic neurologic syndromes (PNS) are a group of disorders that affect the central and the peripheral nervous system and frequently occur in patients…”
Get full text

GABAB receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders by BORONAT, A, SABATER, L, SAIZ, A, DALMAU, J, GRAUS, F

Get full text

GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders by Boronat, A, Sabater, L, Saiz, A, Dalmau, J, Graus, F

“…γ-Aminobutyric acid-B receptor antibodies (GABA(B)R-ab) were recently described in 15 patients with limbic encephalitis (LE), associated with small-cell lung…”
Get full text

Syndrome and outcome of antibody‐negative limbic encephalitis by Graus, F., Escudero, D., Oleaga, L., Bruna, J., Villarejo‐Galende, A., Ballabriga, J., Barceló, M. I., Gilo, F., Popkirov, S., Stourac, P., Dalmau, J.

“…Background and purpose The aim was to report the clinical characteristics of 12 patients with limbic encephalitis (LE) who were antibody‐negative after a…”
Get full text

The expanding field of IgG4-mediated neurological autoimmune disorders by Huijbers, M. G., Querol, L. A., Niks, E. H., Plomp, J. J., van der Maarel, S. M., Graus, F., Dalmau, J., Illa, I., Verschuuren, J. J.

“…At least 13 different disease entities affecting the central nervous system, peripheral nervous system and connective tissue of the skin or kidneys are…”
Get full text

Analysis of relapses in anti-NMDAR encephalitis by GABILONDO, I, SAIZ, A, VINALS, M, VILLOSLADA, P, GRAUS, F, GALAN, L, GONZALEZ, V, JADRAQUE, R, SABATER, L, SANS, A, SEMPERE, A, VELA, A, VILLALOBOS, F

“…The clinical characteristics of patients with relapsing anti-NMDA receptor (NMDAR) encephalitis are not well-defined. In this study, we report the clinical…”
Get full text

Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force by Soffietti, R., Baumert, B.G., Bello, L., Von Deimling, A., Duffau, H., Frénay, M., Grisold, W., Grant, R., Graus, F., Hoang-Xuan, K., Klein, M., Melin, B., Rees, J., Siegal, T., Smits, A., Stupp, R., Wick, W.

“…Background:  Diffuse infiltrative low‐grade gliomas of the cerebral hemispheres in the adult are a group of tumors with distinct clinical, histological and…”
Get full text

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis by BIEN, Christian G, VINCENT, Angela, SUTTON, Ian, LASSMANN, Hans, BAUER, Jan, BARNETT, Michael H, BECKER, Albert J, BLÜMCKE, Ingmar, GRAUS, Francesc, JELLINGER, Kurt A, REUSS, David E, RIBALTA, Teresa, SCHLEGEL, Jürgen

“…Classical paraneoplastic encephalitis syndromes with 'onconeural' antibodies directed to intracellular antigens, and the recently described paraneoplastic or…”
Get full text

SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome by SABATER, L, TITULAER, M, SAIZ, A, VERSCHUUREN, J, GIIRE, A. O, GRAUS, F

“…We reported that 43% of patients with Lambert-Eaton myasthenic syndrome (LEMS) and small cell lung cancer (SCLC) had an antibody called anti-glial nuclear…”
Get full text

THE EXPANDING CLINICAL PROFILE OF ANTI-AMPA RECEPTOR ENCEPHALITIS by GRAUS, F, BORONAT, A, XIFRO, X, BOIX, M, SVIGELJ, V, GARCIA, A, PALOMINO, A, SABATER, L, ALBERCH, J, SAIZ, A

Get full text

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force by Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., Vedeler, C. A., Voltz, R., Verschuuren, J. J. G. M.

“…Background:  Paraneoplastic neurological syndromes (PNS) almost invariably predate detection of the malignancy. Screening for tumours is important in PNS as…”
Get full text

Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes by Ortega Suero, G, Sola-Valls, N, Escudero, D, Saiz, A, Graus, F

“…Analyse the clinical profile, associated tumour types, and response to treatment of paraneoplastic neurological syndromes associated with antibodies against Ma…”
Get full text

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients by Graus, Francesc, Keime-Guibert, Florence, Reñe, Ramón, Benyahia, Baya, Ribalta, Teresa, Ascaso, Carlos, Escaramis, Geòrgia, Delattre, Jean Yves

“…We reviewed 200 patients with paraneoplastic encephalomyelitis (PEM) and anti-Hu antibodies to show possible clinical differences with respect to previous…”
Get full text

Spectrum of paraneoplastic disease associated with lymphoma by BRIANI, C, VITALIANI, R, GRISOLD, W, HONNORAT, J, GRAUS, F, ANTOINE, J. C, BERTOLINI, G, GIOMETTO, B

“…To define the frequency and clinical and immunologic characteristics of patients affected by paraneoplastic neurologic syndromes (PNS) and lymphoma. Patients…”
Get full text

Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes by Storstein, A., Raspotnig, M., Vitaliani, R., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Vedeler, C. A.

“…Prostate cancer is the most common cancer among American and European men. Nervous system affection caused by local tumor growth or osseous metastases are the…”
Get full text

Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience by Ducray, F., Demarquay, G., Graus, F., Decullier, E., Antoine, J.-C., Giometto, B., Psimaras, D., Delattre, J.-Y., Carpentier, A. F., Honnorat, J.

“…Background and purpose To describe the characteristics of patients presenting a paraneoplastic cerebellar degeneration without classical onconeural antibodies…”
Get full text

Management of paraneoplastic neurological syndromes: report of an EFNS Task Force by Vedeler, C. A., Antoine, J. C., Giometto, B., Graus, F., Grisold, W., Hart, I. K., Honnorat, J., Sillevis Smitt, P. A. E., Verschuuren, J. J. G. M., Voltz, R.

“…Paraneoplastic neurological syndromes (PNS) are remote effects of cancer on the nervous system. An overview of the management of classical PNS, i.e…”
Get full text

Recommended diagnostic criteria for paraneoplastic neurological syndromes by Graus, F, Delattre, J Y, Antoine, J C, Dalmau, J, Giometto, B, Grisold, W, Honnorat, J, Smitt, P Sillevis, Vedeler, Ch, Verschuuren, J J G M, Vincent, A, Voltz, R

“…Background: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and exclusion of other known causes of the neurological symptoms,…”
Get full text

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies by Honnorat, J, Cartalat-Carel, S, Ricard, D, Camdessanche, J Ph, Carpentier, A F, Rogemond, V, Chapuis, F, Aguera, M, Decullier, E, Duchemin, A M, Graus, F, Antoine, J C

“…Objective:Anti-Hu antibodies (Hu-Ab) and anti-CV2/CRMP5 antibodies (CV2/CRMP5-Ab) have been identified in association with paraneoplastic neurological…”
Get full text

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months by LLUFRIU, S, CASTILLO, J, GRAUS, F, MONTALBAN, X, SAIZ, A, BLANCO, Y, RAMIO-TORRENTA, L, RIO, J, VALLES, M, LOZANO, M, CASTELLA, M. D, CALABIA, J, HORGA, A

“…Plasma exchange (PE) is used to treat severe episodes of CNS demyelination unresponsive to corticosteroids. Predictors of long-term response are not well…”
Get full text